Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives
Authors
Keywords
-
Journal
Biomarkers in Medicine
Volume 8, Issue 1, Pages 107-118
Publisher
Future Medicine Ltd
Online
2013-12-11
DOI
10.2217/bmm.13.99
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk?
- (2013) Majed S Alokail et al. BMC CANCER
- Leptin at the Intersection of Neuroendocrinology and Metabolism: Current Evidence and Therapeutic Perspectives
- (2013) Maria Dalamaga et al. Cell Metabolism
- Serum resistin: A biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters
- (2013) Maria Dalamaga et al. CLINICAL BIOCHEMISTRY
- Correlates of Serum Resistin in Elderly, Non-Diabetic Patients with Chronic Kidney Disease
- (2013) Anna Marouga et al. Clinical Laboratory
- Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals
- (2013) Hyun-Seuk Moon et al. ENDOCRINE REVIEWS
- Hyperresistinemia is associated with postmenopausal breast cancer
- (2013) Maria Dalamaga et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue
- (2012) Stephen D. Hursting et al. Annals of the New York Academy of Sciences
- Obesity and cancer risk: evidence, mechanisms, and recommendations
- (2012) Ivana Vucenik et al. Annals of the New York Academy of Sciences
- Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls
- (2012) Andreas Hillenbrand et al. BMC CANCER
- Adipokines Linking Obesity with Colorectal Cancer Risk in Postmenopausal Women
- (2012) G. Y. F. Ho et al. CANCER RESEARCH
- Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers
- (2012) L. M. Liao et al. CARCINOGENESIS
- The role of resistin in colorectal cancer
- (2012) Elisa Danese et al. CLINICA CHIMICA ACTA
- Obesity-Driven Inflammation and Colorectal Cancer
- (2012) N. Vazzana et al. CURRENT MEDICINAL CHEMISTRY
- The Role of Adiponectin in Cancer: A Review of Current Evidence
- (2012) Maria Dalamaga et al. ENDOCRINE REVIEWS
- Resistin expression in breast cancer tissue as a marker of prognosis and hormone therapy stratification
- (2012) Yi-Chen Lee et al. GYNECOLOGIC ONCOLOGY
- Genome-wide association analysis identifies TYW3/CRYZ and NDST4 loci associated with circulating resistin levels
- (2012) Qibin Qi et al. HUMAN MOLECULAR GENETICS
- Nicotinamide phosphoribosyl-transferase/visfatin: A missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges
- (2012) Maria Dalamaga MEDICAL HYPOTHESES
- Effects of resistin-like molecule β over-expression on gastric cancer cellsin vitro
- (2012) Li-Duan Zheng WORLD JOURNAL OF GASTROENTEROLOGY
- Resistin: functional roles and therapeutic considerations for cardiovascular disease
- (2011) Md S Jamaluddin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters
- (2011) Maria Dalamaga et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Relationship of resistin levels with endometrial cancer risk
- (2011) M. HLAVNA et al. NEOPLASMA
- Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals
- (2010) Bharat B. Aggarwal Annual Review of Nutrition
- Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation
- (2010) Hae Jong Kim et al. BJU INTERNATIONAL
- Adipocytokine resistin and breast cancer risk
- (2010) Chien-An Sun et al. BREAST CANCER RESEARCH AND TREATMENT
- Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?
- (2010) Mia M. Gaudet et al. Cancer Epidemiology
- Plasma levels of resistin-like molecule beta in humans
- (2010) Andrew P. Neilson et al. Cancer Epidemiology
- Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer
- (2010) Takako Eguchi Nakajima et al. CANCER SCIENCE
- Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection
- (2010) Rosalyn Baker et al. CYTOKINE
- Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer
- (2010) Sayaka Otake WORLD JOURNAL OF GASTROENTEROLOGY
- The role of resistin as a regulator of inflammation: Implications for various human pathologies
- (2009) Mária Filková et al. CLINICAL IMMUNOLOGY
- Genetic variation in adipokine genes and risk of colorectal cancer
- (2009) Sonali Pechlivanis et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma
- (2009) Janne E. Reseland et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Association between adiponectin, resistin, insulin resistance, and colorectal tumors
- (2009) Guzin Gonullu et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Adipocyte-specific Expression of Murine Resistin Is Mediated by Synergism between Peroxisome Proliferator-activated Receptor γ and CCAAT/Enhancer-binding Proteins
- (2009) Takuya Tomaru et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adipocytokines and squamous cell carcinoma of the esophagus
- (2009) Takako Eguchi Nakajima et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Resistin competes with lipopolysaccharide for binding to toll-like receptor 4
- (2009) Andrej Tarkowski et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer
- (2009) Takako Eguchi Nakajima et al. JOURNAL OF GASTROENTEROLOGY
- Serial Plasma Concentrations of Adiponectin, Leptin, and Resistin During Therapy in Children With Acute Lymphoblastic Leukemia
- (2009) Maria Moschovi et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case–control study
- (2008) Maria Dalamaga et al. CANCER CAUSES & CONTROL
- Circulating Levels of Resistin and Risk of Type 2 Diabetes in Men and Women: Results From Two Prospective Cohorts
- (2008) B. H. Chen et al. DIABETES CARE
- Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system
- (2008) Maria Dalamaga et al. EUROPEAN JOURNAL OF CANCER
- Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients
- (2008) Anna Kumor et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
- The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC)
- (2008) Eleni M. Karapanagiotou et al. LUNG CANCER
- Leptin, soluble leptin receptor, adiponectin and resistin in relation to OGTT in overweight/obese postmenopausal women
- (2008) Garifallia Hroussalas et al. MATURITAS
- Adipokines and ghrelin in gastric cancer cachexia
- (2008) Mustafa Kerem et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started